ProMIS Neurosciences, Inc.
PMN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $14,819 | $16,868 | $24,242 | $33,009 |
| - Cash | $15,399 | $4,510 | $8,364 | $13,291 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$580 | $12,358 | $15,878 | $19,718 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11,580 | -$10,117 | -$7,348 | -$238 |
| % Margin | – | – | – | – |
| Net Income | -$11,580 | -$10,117 | -$7,348 | -$238 |
| % Margin | – | – | – | – |
| EPS Diluted | -6 | -7.25 | -5.25 | -0.245 |
| % Growth | 17.2% | -38.1% | -2,042.9% | – |
| Operating Cash Flow | -$10,182 | -$3,854 | -$4,927 | -$8,233 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$10,182 | -$3,854 | -$4,927 | -$8,233 |